TRDA
#3431
Entrada Therapeutics, Inc. - Common Stock
6.7 5 USD
-0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.74%
Monthly Change
+3.37%
6 month change
-37.85%
Year Change
-3.16%
Previous Close
6.8 0
Open
6.7 7
Low
6.6 9
High
6.8 1
Volume
23
Financials
- Market Capitalization 262.04 M
- Employee 152
- Founded 2016
- CEO N/A
- Website www.entradatx.com
- Headquarter Delaware, United States
- FIGI BBG00MTSMC16
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.15
Price to sales ratio
91.18
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3414 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.07 USD | +0.49% | -0.48% | +23.95% | +15.00% | 273.31 M USD | ||
| 3419 |  ALXO ALX Oncology Holdings Inc. - Common Stock | 1.96 USD | -2.00% | -17.30% | +23.27% | +317.02% | 263.74 M USD | ||
| 3440 |  NAGE Niagen Bioscience, Inc. - Common Stock | 3.40 USD | +3.34% | -2.02% | -3.41% | -31.73% | 270.79 M USD | ||
| 3459 |  SRZN Surrozen, Inc. - Common Stock | 21.98 USD | +0.46% | -3.34% | -5.22% | +164.18% | 255.20 M USD |
Frequently asked questions about Entrada Therapeutics, Inc. - Common Stock
What is the Entrada Therapeutics, Inc. - Common Stock stock price today?
The current price of Entrada Therapeutics, Inc. - Common Stock (TRDA) is 6.75. Over the past 24 hours, the stock has changed by -0.74%. Follow the TRDA chart for real-time price dynamics.
What is the stock ticker of Entrada Therapeutics, Inc. - Common Stock?
Entrada Therapeutics, Inc. - Common Stock trades under the ticker TRDA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Entrada Therapeutics, Inc. - Common Stock stock going up?
TRDA has changed by -7.15% over the last week, +3.37% over the last month, and -3.16% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Entrada Therapeutics, Inc. - Common Stock net income for the last quarter?
Entrada Therapeutics, Inc. - Common Stock reported net income of -39.72 M for the last quarter. The previous quarter showed -39.16 M, which means net income changed by -1.41%.
How many employees does Entrada Therapeutics, Inc. - Common Stock have?
As of the latest available data, Entrada Therapeutics, Inc. - Common Stock has 152 employees. Workforce size can provide additional context about the company's scale and operations.
What is Entrada Therapeutics, Inc. - Common Stock EBITDA?
Entrada Therapeutics, Inc. - Common Stock EBITDA is -42.05 M, and its EBITDA margin is -4 805.26%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Entrada Therapeutics, Inc. - Common Stock stock?
You can buy Entrada Therapeutics, Inc. - Common Stock (TRDA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Entrada Therapeutics, Inc. - Common Stock stock?
Investing in Entrada Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TRDA chart and related analysis on metatrader.com as part of your research.